Sponsor or institution
Clinical trials and research at ARS Pharmaceuticals, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by ARS Pharmaceuticals, Inc. that are recruiting, at sites in 2 countries (most in United States (2), Germany (1)). By phase: Phase 2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Outpatient test of ARS-2 for chronic spontaneous urticaria
This trial tests whether a single outpatient dose of ARS-2 helps adults with chronic spontaneous urticaria during moderate-to-severe flares.
-
Neffy versus intramuscular epinephrine for allergic reactions after food challenge or immunotherapy
This trial will test whether Neffy or standard intramuscular epinephrine works and is safe for people aged 4 and up who have allergic reactions during oral food challenges or allergen immunotherapy.
Quick answers
How many clinical trials run by ARS Pharmaceuticals, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (2 trials), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.